The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global Eubiotics Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.

The global Eubiotics market size in 2022 is 4870.0 million US dollars, and it is expected to be 8845.5 million US dollars by 2029, with a compound annual growth rate of 8.90% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Eubiotics market include DSM (Netherlands), Novus International Inc. (U.S.), UAS Laboratories (U.S.) Lallemand Inc. (Canada), Calpis Co. Ltd. (Japan), and Advanced BioNutrition Corp. (U.S.). The share of the top 3 players in the Eubiotics market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Eubiotics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Probiotics accounted for XX% of Eubiotics market in 2022. Prebiotics share of XX%.

Poultry accounted for XX% of the Eubiotics market in 2022. Swine accounts for XX%.

For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.

As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.

Key Factors Considered:

COVID-19

The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.

Regional Conflict / Russia-Ukraine War

The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.

Challenges & Opportunities

Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.

Chapter Outline

Chapter 1: Introduces the product overview, market scope, study objectives and industry dynamic analysis, and then includes the global impact of the coronavirus disease (COVID-19).

Chapter 2: Analysis of the competitive environment of Eubiotics market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.

Chapters 3-5: Segmented the global Eubiotics market by type, application and region. Analyze the revenue of market segments from different perspectives.

Chapter 6: Provide global Eubiotics market size and growth by region.

Chapter 7: Analyzes the main companies in the Eubiotics industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.

Chapter 8: Analyzes the Eubiotics Value Chain, including industrial chain and major downstream buyers.

Chapter 9: The main points and conclusions of the report.

Chapter 10: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Asia Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Latin America

Brazil

Argentina

Mexico

MEA

Saudi Arabia

UAE

Turkey

Player list

DSM (Netherlands)

Novus International Inc. (U.S.)

UAS Laboratories (U.S.) Lallemand Inc. (Canada)

Calpis Co. Ltd. (Japan)

Advanced BioNutrition Corp. (U.S.)

BENEO (Germany)

BEHN MEYER (Germany)

Lesaffre Group (France)

Kemin Industries Inc. (U.S.)

DuPont de Nemours Inc. (U.S.)

Novozymes (Denmark)

Associated British Foods PLC (UK)

Types list

Probiotics

Prebiotics

Organic Acids

Essential Oils

Application list

Poultry

Swine

Ruminants

Table of Content

1 Study Coverage

1.1 Eubiotics Product Introduction

1.2 Global Eubiotics Outlook 2018 VS 2023 VS 2029

1.3 United States Eubiotics Outlook 2018 VS 2023 VS 2029

1.4 Eubiotics Market Size, United States VS Global, 2018-2029

1.4.1 The Market Share of United States Eubiotics in Global, 2018-2029

1.4.2 The Growth Rate of Eubiotics Market Size, United States VS Global, 2018 VS 2023 VS 2029

1.5 Eubiotics Market Dynamics

1.5.1 Eubiotics Market Trends

1.5.2 Eubiotics Market Drivers

1.5.3 Eubiotics Market Challenges

1.5.4 Eubiotics Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Coronavirus Disease (COVID-19) Impact on Global

2 Global Eubiotics Competitor Landscape by Company

2.1 Global Eubiotics Market Size by Company

2.1.1 Top Global Eubiotics Player Ranked by Revenue (2023)

2.1.2 Global Eubiotics Revenue by Player (2018-2023)

2.2 Global Eubiotics Concentration Ratio (CR)

2.2.1 Eubiotics Market Concentration Ratio (CR) (2018-2023)

2.2.2 Global Top 3 and Top 6 Largest Players of Eubiotics in 2023

2.3 Global Eubiotics Business Distribution, Business Type

2.3.1 Global Eubiotics Players, Headquarters and Distribution

2.3.2 Players Eubiotics Business Type

2.3.3 Date of International Players Enter into Eubiotics Market

2.4 Players Mergers & Acquisitions, Expansion Plans

2.5 United States Eubiotics Market Size by Company

2.5.1 Top United States Eubiotics Player s Ranked by Revenue (2023)

2.5.2 United States Eubiotics Revenue by Player (2018-2023)

3 Eubiotics Market Segment by Type

3.1 Eubiotics Market Segment by Type

3.2 Global Eubiotics Market Size by Type

3.3 United States Eubiotics Market Size by Type

4 Eubiotics by Market Segment Application

4.1 Eubiotics Market Segment by Application

4.2 Global Eubiotics Market Size by Application

4.3 United States Eubiotics Market Size by Application

5 Global Eubiotics Market Size by Region

5.1 Global Eubiotics Market Size by Region: 2018 VS 2023 VS 2029

5.2 Global Eubiotics Market Size in Value by Region (2018-2029)

5.2.1 Global Eubiotics Revenue by Region: 2018-2023

5.2.2 Global Eubiotics Revenue by Region: 2023-2029

6 Segment in Regional Level & Country Level

6.1 North America

6.1.1 North America Eubiotics Market Size YoY Growth 2018-2029

6.1.2 North America Eubiotics Market Facts & Figures by Country (2018-2029)

6.1.3 U.S.

6.1.4 Canada

6.2 Asia Pacific

6.2.1 Asia Pacific Eubiotics Market Size YoY Growth 2018-2029

6.2.2 Asia Pacific Eubiotics Market Facts & Figures by Country (2018-2029)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 Southeast Asia

6.3 Europe

6.3.1 Europe Eubiotics Market Size YoY Growth 2018-2029

6.3.2 Europe Eubiotics Market Facts & Figures by Country (2018-2029)

6.3.3 Germany

6.3.4 France

6.3.5 UK

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Eubiotics Market Size YoY Growth 2018-2029

6.4.2 Latin America Eubiotics Market Facts & Figures by Country (2018-2029)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa Eubiotics Market Size YoY Growth 2018-2029

6.5.2 Middle East and Africa Eubiotics Market Facts & Figures by Country (2018-2029)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

7.1 DSM (Netherlands)

7.1.1 Company Details

7.1.2 Description and Business Overview

7.1.3 Eubiotics Introduction

7.1.4 DSM (Netherlands) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.1.5 DSM (Netherlands) Recent Development

7.2 Novus International Inc. (U.S.)

7.2.1 Company Details

7.2.2 Description and Business Overview

7.2.3 Eubiotics Introduction

7.2.4 Novus International Inc. (U.S.) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.2.5 Novus International Inc. (U.S.) Recent Development

7.3 UAS Laboratories (U.S.) Lallemand Inc. (Canada)

7.3.1 Company Details

7.3.2 Description and Business Overview

7.3.3 Eubiotics Introduction

7.3.4 UAS Laboratories (U.S.) Lallemand Inc. (Canada) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.3.5 UAS Laboratories (U.S.) Lallemand Inc. (Canada) Recent Development

7.4 Calpis Co. Ltd. (Japan)

7.4.1 Company Details

7.4.2 Description and Business Overview

7.4.3 Eubiotics Introduction

7.4.4 Calpis Co. Ltd. (Japan) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.4.5 Calpis Co. Ltd. (Japan) Recent Development

7.5 Advanced BioNutrition Corp. (U.S.)

7.5.1 Company Details

7.5.2 Description and Business Overview

7.5.3 Eubiotics Introduction

7.5.4 Advanced BioNutrition Corp. (U.S.) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.5.5 Advanced BioNutrition Corp. (U.S.) Recent Development

7.6 BENEO (Germany)

7.6.1 Company Details

7.6.2 Description and Business Overview

7.6.3 Eubiotics Introduction

7.6.4 BENEO (Germany) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.6.5 BENEO (Germany) Recent Development

7.7 BEHN MEYER (Germany)

7.7.1 Company Details

7.7.2 Description and Business Overview

7.7.3 Eubiotics Introduction

7.7.4 BEHN MEYER (Germany) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.7.5 BEHN MEYER (Germany) Recent Development

7.8 Lesaffre Group (France)

7.8.1 Company Details

7.8.2 Description and Business Overview

7.8.3 Eubiotics Introduction

7.8.4 Lesaffre Group (France) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.8.5 Lesaffre Group (France) Recent Development

7.9 Kemin Industries Inc. (U.S.)

7.9.1 Company Details

7.9.2 Description and Business Overview

7.9.3 Eubiotics Introduction

7.9.4 Kemin Industries Inc. (U.S.) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.9.5 Kemin Industries Inc. (U.S.) Recent Development

7.10 DuPont de Nemours Inc. (U.S.)

7.10.1 Company Details

7.10.2 Description and Business Overview

7.10.3 Eubiotics Introduction

7.10.4 DuPont de Nemours Inc. (U.S.) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.10.5 DuPont de Nemours Inc. (U.S.) Recent Development

7.11 Novozymes (Denmark)

7.11.1 Company Details

7.11.2 Description and Business Overview

7.11.3 Eubiotics Introduction

7.11.4 Novozymes (Denmark) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.11.5 Novozymes (Denmark) Recent Development

7.12 Associated British Foods PLC (UK)

7.12.1 Company Details

7.12.2 Description and Business Overview

7.12.3 Eubiotics Introduction

7.12.4 Associated British Foods PLC (UK) Eubiotics Revenue, Gross, and Gross Margin (2018-2023)

7.12.5 Associated British Foods PLC (UK) Recent Development

8 Value Chain and Sales Channels Analysis

8.1 Eubiotics Value Chain Analysis

8.2 Eubiotics Customers

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology

10.1.1 Research Process

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Legal Disclaimer

List of Tables and Figures

Figure Eubiotics Product Picture

Table Global Eubiotics Revenue, ($), 2018 VS 2023 VS 2029

Figure Global Eubiotics Market Size 2018-2029 ($)

Table United States Eubiotics Revenue, ($), 2018 VS 2023 VS 2029

Figure United States Eubiotics Market Size 2018-2029 ($)

Figure United States Eubiotics Market Share in Global, in Value 2018-2029

Table Eubiotics CAGR in Value, United States VS Global, 2018 VS 2023 VS 2029

Table Eubiotics Market Trends

Table Eubiotics Market Drivers

Table Eubiotics Market Challenges

Table Eubiotics Market Restraints

Figure Eubiotics Report Years Considered

Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021

Figure Population infected by the Covid-19 of Major Countries

Table Top Eubiotics Players in Global Market, Ranking by Revenue (2023)

Table Global Eubiotics Revenue by Player, ($), 2018-2023

Table Global Eubiotics Revenue Share by Player, 2018-2023

Table Global Eubiotics Players Market Concentration Ratio (CR5)

Figure The Top 3 and 6 Largest Players of Eubiotics in the World: Market Share by Eubiotics Revenue in 2023

Table Top Players of Eubiotics in Global Market, Headquarters and Distribution

Table Players Eubiotics Business Type

Table Date of International Players Enter into Eubiotics Market

Table Players Mergers & Acquisitions, Expansion Plans

Table Top Eubiotics Players in United States Market, Ranking by Revenue (2023)

Table United States Eubiotics Revenue by Player, ($), 2018-2023

Table United States Eubiotics Revenue Share by Player, 2018-2023

Table Global Eubiotics Revenue by Type: 2023 VS 2029 ($)

Figure Global Eubiotics Market Share by Type in 2023 & 2029

Figure Global Eubiotics Revenue by Type (2018-2029) & ($)

Figure Global Eubiotics Revenue Market Share in Value by Type (2018-2029)

Table United States Eubiotics Revenue by Type: 2023 VS 2029 ($)

Figure United States Eubiotics Market Share by Type in 2023 & 2029

Figure United States Eubiotics Revenue by Type (2018-2029) & ($)

Figure United States Eubiotics Revenue Market Share in Value by Type (2018-2029)

Table Global Eubiotics Revenue by Application: 2023 VS 2029 ($)

Figure Global Eubiotics Market Share by Application in 2023 & 2029

Figure Global Eubiotics Revenue by Application (2018-2029) & ($)

Figure Global Eubiotics Revenue Market Share in Value by Application (2018-2029)

Table United States Eubiotics Revenue by Application: 2023 VS 2029 ($)

Figure United States Eubiotics Market Share by Application in 2023 & 2029

Figure United States Eubiotics Revenue by Application (2018-2029) & ($)

Figure United States Eubiotics Revenue Market Share in Value by Application (2018-2029)

Table Global Eubiotics Market Size by Region ($): 2018 VS 2023 VS 2029

Figure Global Eubiotics Market Size Market Share by Region: 2018 VS 2023 VS 2029

Table Global Eubiotics Revenue by Region (2018-2023) & ($)

Table Global Eubiotics Revenue Forecast by Region (2023-2029) & ($)

Table Global Eubiotics Revenue Market Share by Region (2018-2029)

Figure North America Eubiotics Revenue Growth Rate 2018-2029

Table North America Eubiotics Revenue by Country (2018-2029) & ($)

Figure U.S. Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Canada Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Asia Pacific Eubiotics Revenue Growth Rate 2018-2029 ($)

Table Asia Pacific Eubiotics Revenue by Country (2018-2029) & ($)

Figure China Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Japan Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure South Korea Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure India Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Australia Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Southeast Asia Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Europe Eubiotics Revenue Growth Rate 2018-2029 ($)

Table Europe Eubiotics Revenue by Country (2018-2029) & ($)

Figure Germany Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure France Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure UK Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Italy Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Russia Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Latin America Eubiotics Revenue Growth Rate 2018-2029 ($)

Table Latin America Eubiotics Revenue by Country (2018-2029) & ($)

Figure Mexico Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Brazil Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Argentina Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Middle East and Africa Eubiotics Revenue Growth Rate 2018-2029 ($)

Table Middle East and Africa Eubiotics Revenue by Country (2018-2029) & ($)

Figure Turkey Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure Saudi Arabia Eubiotics Revenue Growth Rate (2018-2029) & ($)

Figure UAE Eubiotics Revenue Growth Rate (2018-2029) & ($)

Table DSM (Netherlands) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table DSM (Netherlands) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table DSM (Netherlands) Recent Development

Table Novus International Inc. (U.S.) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table Novus International Inc. (U.S.) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table Novus International Inc. (U.S.) Recent Development

Table UAS Laboratories (U.S.) Lallemand Inc. (Canada) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table UAS Laboratories (U.S.) Lallemand Inc. (Canada) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table UAS Laboratories (U.S.) Lallemand Inc. (Canada) Recent Development

Table Calpis Co. Ltd. (Japan) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table Calpis Co. Ltd. (Japan) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table Calpis Co. Ltd. (Japan) Recent Development

Table Advanced BioNutrition Corp. (U.S.) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table Advanced BioNutrition Corp. (U.S.) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table Advanced BioNutrition Corp. (U.S.) Recent Development

Table BENEO (Germany) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table BENEO (Germany) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table BENEO (Germany) Recent Development

Table BEHN MEYER (Germany) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table BEHN MEYER (Germany) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table BEHN MEYER (Germany) Recent Development

Table Lesaffre Group (France) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table Lesaffre Group (France) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table Lesaffre Group (France) Recent Development

Table Kemin Industries Inc. (U.S.) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table Kemin Industries Inc. (U.S.) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table Kemin Industries Inc. (U.S.) Recent Development

Table DuPont de Nemours Inc. (U.S.) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table DuPont de Nemours Inc. (U.S.) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table DuPont de Nemours Inc. (U.S.) Recent Development

Table Novozymes (Denmark) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table Novozymes (Denmark) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table Novozymes (Denmark) Recent Development

Table Associated British Foods PLC (UK) Company Details

Table Description and Business Overview

Table Eubiotics Introduction

Table Associated British Foods PLC (UK) Eubiotics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)

Table Associated British Foods PLC (UK) Recent Development

Figure Eubiotics Value Chain

Table Major Customers of Eubiotics with Contact Information

Table Research Process

Figure Bottom-up and Top-down Approaches for This Report